- Home
- OPAD vs DARE Comparison
OPAD vs DARE Comparison
Compare OPAD & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPAD
- DARE
- Stock Information
- Founded
- OPAD 2015
- DARE 2015
- Country
- OPAD United States
- DARE United States
- Employees
- OPAD N/A
- DARE N/A
- Industry
- OPAD Real Estate
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- OPAD Finance
- DARE Health Care
- Exchange
- OPAD Nasdaq
- DARE Nasdaq
- Market Cap
- OPAD 25.3M
- DARE 26.3M
- IPO Year
- OPAD N/A
- DARE N/A
- Fundamental
- Price
- OPAD $1.37
- DARE $4.73
- Analyst Decision
- OPAD Hold
- DARE Strong Buy
- Analyst Count
- OPAD 5
- DARE 3
- Target Price
- OPAD $2.38
- DARE $12.50
- AVG Volume (30 Days)
- OPAD 142.8K
- DARE 452.0K
- Earning Date
- OPAD 08-04-2025
- DARE 08-11-2025
- Dividend Yield
- OPAD N/A
- DARE N/A
- EPS Growth
- OPAD N/A
- DARE N/A
- EPS
- OPAD N/A
- DARE N/A
- Revenue
- OPAD $794,159,000.00
- DARE $25,909.00
- Revenue This Year
- OPAD N/A
- DARE $99,756.91
- Revenue Next Year
- OPAD $40.79
- DARE $119.77
- P/E Ratio
- OPAD N/A
- DARE N/A
- Revenue Growth
- OPAD N/A
- DARE N/A
- 52 Week Low
- OPAD $0.91
- DARE $2.11
- 52 Week High
- OPAD $5.13
- DARE $4.60
- Technical
- Relative Strength Index (RSI)
- OPAD 70.23
- DARE 41.75
- Support Level
- OPAD $0.91
- DARE $2.37
- Resistance Level
- OPAD $1.59
- DARE $2.54
- Average True Range (ATR)
- OPAD 0.13
- DARE 0.14
- MACD
- OPAD 0.06
- DARE -0.00
- Stochastic Oscillator
- OPAD 77.94
- DARE 59.56
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.